Epigenetic regulation of gelsolin expression in human breast cancer cells

Experimental Cell Research

Volumn 249, Issue 1, 1999, Pages 161-176

  Mielnicki, Lawrence M ^a   Ying, Angela M ^a   Head, Karen L ^a   Asch, Harold L ^a   Asch, Bonnie B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Breast cancer; DNA methylation; Gelsolin; Hyperacetylation

Indexed keywords

GELSOLIN; HISTONE;

ACETYLATION; ARTICLE; BREAST CANCER; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0033602765     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4461     Document Type: Article

References (90)

1. Yin H. L. Gelsolin: Calcium- and polyphosphoinositide-regulated actin-modulating protein. Bioessays. 7:1988;176-179.
2. Khaitlina S., Hinssen H. Conformational changes in actin induced by its interaction with gelsolin. Biophys. J. 73:1997;929-937.
3. Wegner A., Aktories K., Ditsch A., Just I., Schoepper B., Selve N., Wille M. Actin-gelsolin interaction. Actin: Biophysics, Biochemistry and Cell Biology. 1994;Plenum Press, New York. p. 97-104.
4. Wolfgang K., Vandekerckhove J. Structure and function of actin. Annu. Rev. Biophys. Biomol. Struct. 21:1992;49-76.
5. Welch M. D., Mallavarapu A., Rosenblatt J., Mitchison T. J. Actin dynamicsin vivo. Curr. Opin. Cell Biol. 9:1997;54-61.
6. Janmey P. A., Chaponnier C. Medical aspects of the actin cytoskeleton. Curr. Opin. Cell Biol. 7:1995;111-117.
7. Higley S., Way M. Actin and cell pathogenesis. Curr. Opin. Cell Biol. 9:1997;62-69.
8. Cunningham C. C., Stossel T. P., Kwiatkowski D. J. Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science. 251:1991;1233-1236.
9. Arora P. D., McCullogh C. A. G. Dependence of fibroblast migration on actin severing activity of gelsolin. J. Biol. Chem. 271:1996;20516-20523.
10. Assoian R. K., Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9:1997;93-98.
11. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T. J., Kirschner M. W., Koths K., Kwiatkowski D. J., Williams L. T. Caspase-3 generated fragment of gelsolin: Effector of morphological change in apoptosis. Science. 278:1997;294-298.
12. Ohtsu M., Sakai N., Fujita H., Kashiwagi M., Gasa S., Shimizu S., Eguchi Y., Tsujimoto Y., Sakiyama Y., Kobayashi K., Kuzumaki N. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J. 16:1997;4650-4656.
13. Singh S. S., Chauhan A., Murakami N., Chauhan V. P. S. Profilin and gelsolin stimulate phosphatidylinositol 3-kinase activity. Biochemistry. 35:1996;16544-16549.
14. c-src. FEBS Lett. 401:1997;191-196.
15. Sun H., Lin K., Yin H. L. Gelsolin modulates phospholipase C activityin vivo. J. Cell Biol. 138:1997;811-820.
16. Chen P., Murphy-Ullrich J. E., Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J. Cell Biol. 134:1996;689-698.
17. Steed P. M., Nagar S., Wennogle L. P. Phospholipase D regulation by a physical interaction with the actin-binding protein gelsolin. Biochemistry. 35:1996;5229-5237.
18. Arcaro A. The small GTP-binding protein Rac promotes the dissociation of gelsolin from actin filaments in neutrophils. J. Biol. Chem. 273:1998;805-813.
19. Azuma T., Witke W., Stossel T. P., Hartwig J. H., Kwiatkowski D. J. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J. 17:1998;1362-1370.
20. Tanaka M., Müllauer L., Ogiso Y., Fujita H., Moriya S., Furuuchi K., Harabayashi T., Shinohara N., Koyanagi T., Kuzumaki N. Gelsolin: A candidate for suppressor of bladder cancer. Cancer Res. 53:1995;3228-3232.
21. Müllauer L., Fujita H., Ishizaki A., Kuzumaki N. Tumor-suppressive function of mutated gelsolin in ras-transformed cells. Oncogene. 8:1993;2531-2536.
22. Chaponnier C., Gabbiani G. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma. Am. J. Pathol. 134:1989;597-603.
23. Medina D., Kittrell F. S., Oborn C. J., Schwartz M. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells. Cancer Res. 53:1993;668-674.
24. Zhang L., Zhou W., Velculescu V. E., Kern S. E., Hruban R. H., Hamilton S. R., Vogelstein B., Kinzler K. W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272.
25. Asch H. L., Head K., Dong Y., Natoli F., Winston J. S., Connolly J. L., Asch B. B. Widespread loss of gelsolin expression in breast cancers of humans, mice, and rats. Cancer Res. 56:1996;4841-4846.
26. Kwiatkowski D. J., Westbrook C. A., Bruns G. A. P., Morton C. C. Localization of gelsolin proximal to ABL on chromosome 9. Am. J. Hum. Genet. 42:1988;565-572.
27. Orlow I., Lianes P., Lacombe L., Dalbagni G., Reuter V. E., Cordon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res. 54:1994;2848-2851.
28. Kwiatkowski D. J., Mehl R., Yin H. L. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J. Cell Biol. 106:1988;375-384.
29. Gardiner-Gardin M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 196:1987;261-282.
30. Laird P. W., Jaenisch R. The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet. 30:1996;441-464.
31. Kass S. U., Pruss D., Wolffe A. P. How does DNA methylation repress transcription. Trends Genet. 13:1997;444-449.
32. Hoshikawa Y., Kwan H. J., Yoshida M., Horinouchi S., Beppu T. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp. Cell Res. 214:1994;189-197.
33. Li X., Yoshida M., Beppu T., Lotan R. Modulation of growth and differentiation of human colon carcinoma cells by histone deacetylase inhibitory trichostatins. Int. J. Oncol. 8:1996;431-437.
34. Yoshida M., Horinouchi S., Beppu T. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays. 17:1995;423-430.
35. Wade P. A., Pruss D., Wolffe A. P. Histone acetylation: Chromatin in action. TIBS. 22:1997;128-132.
36. Stampfer M. R., Bartley J. C. Human mammary epithelial cells in culture: Differentiation and transformation. Lippmann M. E., Dickson R. B. Breast Cancer: Cellular and Molecular Biology. 1988;1-24 Kluwer, Boston.
37. Clarke R., Leonessa F., Brunner N., Thompson E. W. In vitro. Harris J. R., Hellman S., Lippman M. E., Morrow M. Diseases of the Breast. 1995;245-261 Lippincott, Philadelphia.
38. Rheaume C., Latimer J. J., Baumann H., Berger F. G. Tissue- and species-specific regulation of murine alpha 1-antitrypsin gene transcription. J. Biol. Chem. 263:1988;15118-15121.
39. Mohler W. A., Charlton C. A., Blau H. M. Spectrophotometric quantitation of tissue culture cell number in any medium. Biotechniques. 21:1996;260-263.
40. L. J. Biol. Chem. 273:1998;4523-4529.
41. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
42. Puissant C., Houdebine L. One-step method for the isolation of RNA using acid guanidinium isothiocyanate. BioTechnology. 8:1990;148-149.
43. Church G. M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
44. Jacobsen A., Peltz S. W. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu. Rev. Biochem. 65:1996;693-739.
45. Ghibelli L., Maresca V., Coppola S., Gualandi G. Protease inhibitors block apoptosis at intermediate stages. A compared analysis of DNA fragmentation and apoptotic nuclear morphology. FEBS Lett. 377:1995;9-14.
46. Erenpreisa J., Freivalds T., Roach H., Alston R. Apoptotic cell nuclei favour aggregation and fluorescence quenching of DNA dyes. Histochem. Cell. Biol. 108:1997;67-75.
47. Blankenberg F. G., Katsikis P. D., Storrs R. W., Beaulieu C., Spielman D., Chen J. Y., Naumovski L., Tait J. F. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood. 89:1997;3778-3786.
48. Bhakoo K. K., Bell J. D. The application of NMR spectroscopy to the study of apoptosis. Cell. Mol. Biol. 43:1997;621-629.
49. Ferguson A. T., Lapidus R. G., Davidson N. E. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression. Oncogene. 17:1998;577-583.
50. Wicki R., Franz C., Scholl F. A., Heizmann C. W., Schäfer B. W. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium. 22:1997;243-254.
51. Mizumoto Y., Kimura T., Ivell R. A genomic element within the third intron of the human oxytocin receptor gene may be involved in transcriptional repression. Mol. Cell. Endocrinol. 135:1997;129-138.
52. Davey C., Pennings S., Allan J. CpG methylation remodels chromatin structurein vitro. J. Mol. Biol. 267:1997;276-288.
53. Foster S. A., Wong D. J., Barrett M. T., Galloway D. A. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18:1998;1793-1801.
54. Hiraguri S., Godfrey T., Nakamura H., Graff J., Collins C., Shayesteh L., Dogget N., Johnson K., Wheelock M., Herman J., Baylin S., Pinkel D., Gray J. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res. 58:1998;1972-1977.
55. Dobrovic A., Simpfendorfer D. Methylation of theBRCA1. Cancer Res. 57:1997;3347-3350.
56. Counts J. L., Goodman J. I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell. 83:1995;13-15.
57. Graff J. R., Herman J. G., Myöhänen S., Baylin S. B., Vertino P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicate both upstream and downstream regions inde novo. J. Biol. Chem. 272:1997;22322-22329.
58. Chen Z., Ko A., Yang J., Jordan V. C. Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. Br. J. Cancer. 77:1998;181-185.
59. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352.
60. Pazin M. J., Kadonaga J. T. What's up and down with histone deacetylation and transcription. Cell. 89:1997;325-328.
61. Mandal M., Kumar R. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ. 7:1996;311-318.
62. Medina V., Edmonds B., Young G. P., James R., Appleton S., Zalewski P. D. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 57:1997;3697-3707.
63. Dong, Y. Asch, H. Medina, D. Ip, C. Ip, M. Guzman, R. Asch, B. Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers, Int. J. Cancer.
64. Razin A. CpG methylation, chromatin structure and gene silencing - A three way connection. EMBO J. 17:1998;4905-4908.
65. Imhof A., Xiang-Jiao Y., Ogryzko V. V., Nakatani Y., Wolffe A. P., Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:1997;689-692.
66. Kass S. U., Landsberger N., Wollfe A. P. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7:1997;157-165.
67. Dangond F., Hafler D. A., Tong J. K., Randall J., Kojima R., Utku N., Gullans S. R. Differential display cloning of a novel human histone deacetylase (HDAC3) from PHA-activated immune cells. Biochem. Biophys. Res. Commun. 242:1998;648-652.
68. Nan X., Ng H.-H., Johnson C. A., Laherty C. D., Turner B. M., Eisenman R. N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 393:1998;386-389.
69. Hassig C. A., Tong J. K., Fleischer T. C., Owa T., Grable P. G., Ayer D. E., Schreiber S. L. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA. 95:1998;3519-3524.
70. Selker E. U. Trichostatin A causes a selective loss of DNA methylation inNeurospora. Proc. Natl. Acad. Sci. USA. 95:1998;9430-9435.
71. Chen Z. J., Pikaard C. S. Epigenetic silencing of RNA polymerase I transcription: A role for DNA methylation and histone modification in nucleolar dominance. Genes Dev. 11:1997;2124-2136.
72. Monmey L., Otter I., Olivier R., Ozer H. L., Haas A. L., Omura S., Borner C. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by bcl-2. J. Biol. Chem. 273:1998;6121-6131.
73. Meriin A. B., Gabai V. L., Yaglom J., Shifrin V. I., Sherman M. Y. Proteasome inhibitors activate stress kinases and induce hsp72. Diverse effects on apoptosis. J. Biol. Chem. 273:1998;6373-6379.
74. Arts J., Lansink M., Grimbergen J., Toet K. H., Kooistra T. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem. J. 310:1995;171-176.
75. McCaffrey P. G., Newsome D. A., Fibach E., Yoshida M., Su M. S.-S. Induction of γ-globin by histone deacetylase inhibitors. Blood. 90:1997;2075-2083.
76. Jin S., Scotto K. W. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:1998;4377-4384.
77. Takahashi I., Miyaji H., Yoshida T., Sato S., Mizukami T. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. J. Antibiotics. 49:1996;453-457.
78. Huang N., Katz J. P., Martin D. R., Wu G. D. Inhibition of IL-8 gene expression in CACO-2 cells by compounds which induce histone hyperacetylation. Cytokine. 9:1997;27-36.
79. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Express. 5:1996;245-253.
80. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606.
81. Coradini D., Biffi A., Costa A., Pellizzaro C., Pironello E., Di Fronzo G. Effect of sodium butyrate on human breast cancer cell lines. Cell Prolif. 30:1997;149-159.
82. McBain J. A., Eastman A., Nobel C. S., Mueller G. C. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem. Pharmacol. 53:1997;1357-1368.
83. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell. 14:1978;115-121.
84. Boffa L. C., Vidali G., Mann R. S., Allfrey V. G. Suppression of histone deacetylationin vivoin vitro. J. Biol. Chem. 253:1978;3364-3366.
85. Jänicke R. U., Sprengart M. L., Wati M. R., Porter A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
86. Marini M., Musiani D., Sestili P., Cantoni O. Apoptosis of human lymphocytes in the absence or presence of internucleosomal DNA cleavage. Biochem. Biophys. Res. Commun. 229:1996;910-915.
87. Dong Z., Saikumar P., Weinberg J. M., Venkatachalam M. A. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Am. J. Pathol. 151:1997;1205-1213.
88. Bonsing B. A., Corver W. E., Gorsira M. C. B., Vanvliet M., Oud P. S., Cornelisse C. J., Fleuren G. J. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Cytometry. 28:1997;11-24.
89. Katayose D., Gudas J., Nguyen H., Srivastava S., Cowan K. H., Seth P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1:1995;889-897.
90. Witke W., Sharpe A. H., Hartwig J. H., Azuma T., Stossel T. P., Kwiatkowski D. J. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell. 81:1995;41-51.